Adverse effects | No. of studies | TP group (event/total) | IPC group (event/total) | RR (95% CI) | P value | Heterogeneity | |
---|---|---|---|---|---|---|---|
I2 (%) | P value | ||||||
Pleural infection | 2 | 2/126 | 7/126 | 0.28 [0.06, 1.32] | 0.11 | 0 | 0.54 |
Pain | 2 | 1/100 | 3/101 | 0.61 [0.03, 12.92] | 0.75 | 50 | 0.16 |
Dyspnea/breathlessness | 1 | 2/29 | 0/28 | 4.83 [0.24, 96.42] | 0.30 | NA | NA |
Catheter blockage | 1 | 1/54 | 1/52 | 0.96 [0.06, 15.00] | 0.98 | NA | NA |
Cellulitis | 1 | 0/54 | 1/52 | 0.32 [0.01, 7.71] | 0.48 | NA | NA |